Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnylam Pharmaceuticals IncfiledCriticalAlnylam Pharmaceuticals Inc
Publication of AR110225A1publicationCriticalpatent/AR110225A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Agentes de ARNi, por ejemplo, agentes de ARNi de hebra doble, direccionados al gen de Serpina1 y métodos para usar dichos agentes de ARNi para inhibir la expresión de Serpina1 y métodos de tratamiento de sujetos que padecen una enfermedad asociada con Serpina1, tal como un trastorno hepático.RNAi agents, for example, double-stranded RNAi agents, directed to the Serpina1 gene and methods for using said RNAi agents to inhibit the expression of Serpina1 and methods of treating subjects suffering from a disease associated with Serpina1, such as a liver disorder
ARP170103272A2016-11-232017-11-23
COMPOSITIONS OF ARNi DE SERPINA1 AND ITS METHODS OF USE
AR110225A1
(en)